Objective To assess the feasibility of conducting a cluster randomised controlled trial comparing the effects of Advanced ...
Writing in JAMA, regulators said randomized controlled trials with a survival or time-to-event endpoint would be expected for approval of a new CAR T-cell therapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback